Search Within

Paul K Paik

Formats
  1. Meeting Abstract (168)
  2. Journal Article (83)
  3. Review (4)
  4. Book Section (1)
Groups
  1. Department of Medicine (256)
  2. Solid Tumor Oncology Division (256)
  3. Thoracic Oncology (256)
  4. GSK Faculty (77)
  5. Department of Pathology and Laboratory Medicine (74)
  6. Human Oncology and Pathogenesis Program (55)

More Groups

People
  1. Mark Kris (55)
  2. Marc Ladanyi (47)
  3. Gregory Riely (42)
  4. Natasha Rekhtman (41)
  5. Charles Rudin (40)
  6. Jamie Chaft (33)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (32)
  4. 2022 (39)
  5. 2021 (34)
  6. 2020 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (49)
  3. Annals of Oncology (34)
  4. Clinical Cancer Research (12)
  5. International Journal of Radiation Oncology, Biology, Physics (11)
  6. Clinical Lung Cancer (6)

More Publications

Publishers
  1. Elsevier Inc. (81)
  2. American Society of Clinical Oncology (56)
  3. Oxford University Press (38)
  4. American Association for Cancer Research (22)
  5. Wiley Blackwell (12)
  6. Nature Publishing Group (11)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
    Journal Article

    Lovly, C. M.; McDonald, N. T.; Chen, H.; Ortiz-Cuaran, S.; Heukamp, L. C.; Yan, Y.; Florin, A.; Ozretić, L.; Lim, D. ; Wang, L.; more...
    Nature Medicine (2014)

    Fulltext@MSK | Save
  • Stage III non-small cell lung cancer treated without concurrent chemotherapy: What is the optimal radiation dose?
    Meeting Abstract

    Rimner, A.; Din, S.; Shaikh, F.; Foster, A.; Tyagi, N.; Aad, S. A.; Paik, P.; Yorke, E. D.; Chaft, J. E.; Gelblum, D. Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K-aberrant and FGFR1 amplified stage IV squamous cell lung cancers (SQCLCs)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Rekhtman, N.; Sima, C. S.; Won, H.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)
    Meeting Abstract

    Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Histological prognostic markers in squamous cell carcinoma of the lung
    Meeting Abstract

    Drilon, A.; Sima, C. S.; Paik, P. K.; Moreira, A. L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Journal Article

    Yu, H. A.; Sima, C. S.; Huang, J.; Solomon, S. B.; Rimner, A.; Paik, P.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save